0001209191-22-057531.txt : 20221117 0001209191-22-057531.hdr.sgml : 20221117 20221117161522 ACCESSION NUMBER: 0001209191-22-057531 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221116 FILED AS OF DATE: 20221117 DATE AS OF CHANGE: 20221117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PISKEL KYLE CENTRAL INDEX KEY: 0001780662 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 221398529 MAIL ADDRESS: STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION STREET 2: 1551 EASTLAKE AVE E STE 200 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-11-16 2022-11-17 0 0001478320 Adaptive Biotechnologies Corp ADPT 0001780662 PISKEL KYLE C/O ADAPTIVE BIOTECHNOLOGIES CORP. 1165 EASTLAKE AVE E SEATTLE WA 98109 0 1 0 0 Principal Accounting Officer Common Stock 2022-11-16 4 S 0 307 8.87 D 47358 D This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding olbigaitons to e funded by a sell to cover transaction and does not represent a discretionary trade. /s/ Kyle Piskel by Eric Billings, attorney-in-fact 2022-11-17